Kentucky AI Healthcare Regulations: A Comprehensive Guide

Quick Answer: AI Healthcare Regulations in Kentucky

For AI deployment or use in Kentucky healthcare, federal agencies—chiefly the FDA and HHS—set the primary rules. The FDA regulates AI that meets the definition of a medical device or Software as a Medical Device (SaMD). HIPAA governs any AI system that touches Protected Health Information (PHI). Kentucky has not passed a standalone AI healthcare law, but existing Kentucky Revised Statutes (KRS) covering medical licensure, professional conduct, telehealth, and patient consent all apply to AI-assisted care. The physician or licensed provider using the AI tool remains responsible for clinical decisions. Ethical deployment, data security, and patient safety are embedded in existing law, even without explicit mention of AI.

Federal vs. Kentucky Regulatory Framework for AI in Healthcare

FDA: The Primary Gatekeeper for AI as a Medical Device

When an AI system is intended to diagnose, treat, cure, mitigate, or prevent a disease or condition, the FDA classifies it as a medical device under 21 U.S.C. §321(h). AI and machine learning tools that meet this definition are regulated as SaMD. The FDA's premarket review process, including 510(k) clearance, De Novo classification, and Premarket Approval (PMA), applies depending on the device's risk classification.

The FDA has issued specific guidance on AI/ML-Based Software as a Medical Device, outlining a framework for "predetermined change control plans" that allow developers to update algorithms without a new submission for every iteration. Postmarket surveillance obligations under 21 CFR Part 820 (Quality System Regulation, transitioning to alignment with ISO 13485 under 21 CFR Part 820 as amended) require manufacturers to monitor real-world performance, report adverse events, and maintain corrective action systems. A 2026 cross-sectional analysis of FDA-authorized oncology AI/ML devices found that clinical evidence supporting many cleared devices remains limited (Litt H et al., Journal of Cancer Policy, 2026, PubMed ID 42025919), underscoring the importance of postmarket surveillance.

Kentucky providers and health systems purchasing or deploying FDA-cleared AI tools should verify the device's 510(k) or PMA number through the FDA's 510(k) database before clinical use. Deploying an AI diagnostic tool that has not received appropriate FDA authorization exposes the facility to federal enforcement action.

HIPAA: Applies Everywhere PHI Goes, Including AI Systems

Any AI system that processes, stores, or transmits PHI in Kentucky is subject to the HIPAA Privacy Rule, Security Rule, and Breach Notification Rule (45 CFR Parts 160, 162, and 164). This means:

• AI vendors with access to PHI must execute a Business Associate Agreement (BAA) before receiving data (45 CFR §164.502(e)).
• Security Risk Analyses must account for AI systems as part of the covered entity's electronic PHI environment (45 CFR §164.308(a)(1)).
• Breach notification timelines and obligations apply if an AI system is involved in an unauthorized disclosure (45 CFR §164.400 et seq.).

HHS Office for Civil Rights (OCR) enforces HIPAA and has issued guidance clarifying that AI tools used by covered entities and business associates are not exempt from these requirements. Consult HHS OCR directly for current enforcement priorities.

Kentucky's Role: Licensure, Conduct, and Facility Oversight

Kentucky does not have a dedicated AI healthcare statute as of the date of this publication. The state's authority operates through:

• Medical licensure and professional conduct standards administered by the Kentucky Board of Medical Licensure (KBML).
• Healthcare facility licensing and oversight by the Kentucky Cabinet for Health and Family Services (CHFS).
• General consumer protection authority under KRS Chapter 367.

Kentucky cannot override FDA device approval requirements, but it can discipline a licensed physician who uses an AI tool negligently, fails to supervise AI-generated recommendations, or abandons the standard of care.

Existing Kentucky Laws Indirectly Impacting AI in Healthcare

Medical Practice and Physician Responsibility

KRS Chapter 311 governs the practice of medicine and osteopathy in Kentucky. The KBML enforces standards of professional conduct, and 201 KAR 9:016 defines unprofessional conduct, which includes acts or omissions that fall below the accepted standard of care. A physician who blindly follows an AI diagnostic recommendation without applying clinical judgment can face licensure action under this framework.

The standard of care analysis does not change because an AI tool was involved. If a reasonable physician in the same specialty would have caught an error that the AI produced, the physician using the AI is still exposed to a board complaint and civil liability. The KBML has not issued specific written guidance on AI use by licensees as of the preparation of this page. Consult the KBML directly for current policy positions.

Telehealth and AI-Powered Remote Tools

KRS 311.5975 establishes Kentucky's telehealth framework, requiring that telehealth services meet the same standard of care as in-person services. AI-powered diagnostic tools, remote patient monitoring systems, and clinical decision support software used in a telehealth context must comply with this standard. The statute does not carve out an exception for AI-assisted encounters.

Kentucky also requires that a valid patient-provider relationship exist before telehealth services are delivered (KRS 311.5975(3)). If an AI tool is the primary point of patient interaction without a licensed provider in the loop, that arrangement likely violates the statute. Providers integrating AI into telehealth workflows should document the provider's review and approval of AI-generated outputs in the patient record.

Patient Consent and Health Information

Kentucky does not have a comprehensive consumer data privacy law equivalent to California's CCPA that would independently govern AI use in healthcare beyond HIPAA. KRS Chapter 214 addresses communicable disease reporting and certain public health data, but does not create a broad patient data privacy framework that supplements HIPAA for AI purposes.

Kentucky statute does not settle whether providers must specifically disclose AI involvement in diagnosis or treatment planning. However, ethical and liability risks exist for failing to disclose significant AI involvement. Consult legal counsel on consent form language if AI tools are a material part of the diagnostic or treatment process.

Consumer Protection

KRS Chapter 367 (Kentucky Consumer Protection Act) prohibits unfair, false, misleading, or deceptive acts in trade or commerce. A healthcare organization that markets AI-powered services with exaggerated accuracy claims, or that fails to disclose known limitations of an AI diagnostic tool, could face action from the Kentucky Attorney General under this chapter.

Key Considerations for AI Deployment in Kentucky Healthcare

Data Governance and Security

AI systems in healthcare generate, consume, and store large volumes of sensitive data. Kentucky providers must:

• Conduct a HIPAA Security Risk Analysis that explicitly includes AI systems and their data flows (45 CFR §164.308(a)(1)).
• Require BAAs from all AI vendors with PHI access.
• Establish data retention and deletion policies that account for training data, model outputs, and audit logs.
• Verify that AI vendors operating in cloud environments meet the technical safeguard requirements of 45 CFR §164.312.

Algorithmic Bias and Equitable Care

Kentucky's patient population includes significant rural, low-income, and underserved communities. AI models trained primarily on data from urban academic medical centers may perform poorly for these populations. Providers have an ethical and, arguably, a standard-of-care obligation to evaluate whether an AI tool has been validated on populations similar to their patient base before deploying it clinically. Ask vendors for demographic performance breakdowns before signing a contract.

Liability for AI-Driven Clinical Decisions

Kentucky medical malpractice law (KRS Chapter 342 and common law negligence standards) does not recognize AI as a separate legal actor. The licensed provider remains the responsible party. If an AI tool produces a wrong recommendation and the provider acts on it without independent clinical review, the provider, and potentially the facility, faces liability. AI vendors may attempt to limit liability through contract terms, but those limitations do not transfer the provider's professional duty to the patient.

Transparency, Explainability, and Human Oversight

Providers should be able to explain, in plain terms, how an AI tool contributed to a clinical decision. "The algorithm said so" is not a defensible clinical note. Documenting the AI tool used, its output, and the provider's independent clinical reasoning for the final decision is best practice. This protects the provider in licensure or malpractice proceedings and supports patient trust.

Informed Consent for AI Use

While Kentucky has no statute mandating AI-specific consent disclosures, the general informed consent doctrine requires disclosure of material information. If AI involvement is material to the patient's understanding of their care, disclose it. Update consent forms and patient-facing materials to reflect AI use in diagnosis, treatment planning, or monitoring.

Comparison: Federal vs. State Oversight of AI in Healthcare

Areas of overlap are where compliance gaps most commonly appear. A facility may have FDA-cleared AI software and a signed BAA, but still face KBML action if a physician fails to exercise independent clinical judgment over the tool's outputs.

Next Steps and Key Contacts for AI Healthcare Stakeholders in Kentucky

Kentucky Board of Medical Licensure (KBML)

Contact the KBML for questions about professional conduct standards, supervision requirements, and any current guidance on AI use by licensed physicians.

• Address: 310 Whittington Parkway, Suite 1B, Louisville, KY 40222
• Phone: (502) 429-7150
• Website: kbml.ky.gov

The KBML has not published formal AI-specific guidance as of this writing. Ask directly whether any advisory opinions or policy statements have been issued since this page was prepared.

Kentucky Cabinet for Health and Family Services (CHFS)

CHFS oversees healthcare facility licensing and Medicaid program administration in Kentucky. For questions about AI use in Medicaid-funded programs or facility compliance:

• Website: chfs.ky.gov
• Office of Inspector General (facility licensing): (502) 564-2888

Federal Agencies

• FDA Center for Devices and Radiological Health (CDRH): For SaMD classification, 510(k) database searches, and AI/ML guidance documents. Visit fda.gov/medical-devices and search "artificial intelligence."
• HHS Office for Civil Rights (HIPAA): For HIPAA compliance questions related to AI systems. Visit hhs.gov/ocr or call 1-800-368-1019.
• HHS Office of the National Coordinator for Health IT (ONC): ONC has issued rules on information blocking and interoperability that intersect with AI data pipelines (45 CFR Part 171). Visit healthit.gov.

Legal Counsel

Retain counsel with experience in both healthcare regulatory law and technology transactions before deploying AI tools in a clinical setting. Kentucky Bar Association's Health Law section can provide referrals. Contract review, BAA negotiation, consent form drafting, and liability allocation in vendor agreements all require attorney involvement. This page is a regulatory reference, not legal advice.

Staying Current

Kentucky's legislative session runs annually. Monitor the Kentucky Legislature's bill tracking system (legislature.ky.gov) for any AI-specific healthcare bills introduced in the current or upcoming session. At the federal level, subscribe to FDA CDRH email updates and HHS OCR guidance announcements. The AI healthcare regulatory landscape evolves rapidly; a compliance posture adequate today may require revision within 12 to 18 months.